Comparison of clinical efficacy between twice-daily formoterol/budesonide combinations and once-daily fluticasone furoate/vilanterol in bronchial asthma
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000015609
- Lead Sponsor
- Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine
- Brief Summary
Forty-two patients with asthma were enrolled (21 patients, pack-year<10) in this study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) treatment with oral or intravenous corticosteroids in the previous 4weeks, or (2) other pulmonary diseases, including chronic obstructive pulmonary disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline (0 week) in FEV1 after 8 weeks of treatment
- Secondary Outcome Measures
Name Time Method Secondly end points are change in QOL (ACT score, ACQ score), fractional exhaled nitric oxide, forced oscillation technique and adherence after 8 weeks of treatment from baseline (0 week). Adverse events are reported throughout the study